Clinical Trial: A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07441278) titled 'A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)' on Jan. 30.

Brief Summary: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Dose Finding Trial to Evaluate the Efficacy and Safety of Orally Administered NS-863 in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)

Study Start Date: July 01, 2026

Study Type: INTERVENTIONAL

Condition: Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Intervention: DRUG: NS-863 Low Dose

NS-863 is an orally administered drug.

DRUG: NS-863 High Dose

NS-...